Pharmaceutical and Biological Products Contract Development and Manufacturing

Pharmaceutical and Biological Products Contract Development and Manufacturing
Product Description

Bora Pharmaceuticals is a premier international contract development and manufacturing organization (CDMO). Our six state-of-the-art cGMP manufacturing facilities across Asia and North America deliver to more than 100 markets around the world. Our sites have the highest industry standards for quality, development, manufacturing, packaging, and analytical testing. We specialize in complex oral solids, liquids, semi-solids, ophthalmics and nasal sprays for pharmaceutical Rx and OTC products. Bora can provide solutions from early phase clinical through to commercial manufacturing with full packaging and serialization capabilities. Our large molecule offerings include cell-line development, formulation development, analytical services, and clinical manufacturing to support our partners. As a future focused CDMO, we know better than most that our own success is shaped by our partners victories. That's why, when you choose Bora - we make success more certain by following Bora’s 5Ps – Promises, Partnerships, Pride, People, and Progress. These 5 principles are Bora’s Pledge to our customers.

Bora Pharmaceuticals

  • CA
  • 2022
    On CPHI since

Bora Pharmaceuticals

  • CA
  • 2022
    On CPHI since

Bora Pharmaceuticals resources (1)

  • News CPHI Barcelona 2023: Tackling the Pharma Talent Precipice – Part 1

    This year at CPHI Barcelona (24–26 October, 2023) we sat down with C-suite executives and HR professionals to discuss the looming talent crisis in the pharmaceutical industry. With hybrid working persisting post-pandemic and a growing skills gap, how can the pharmaceutical supply chain adjust to a changing labour force?